StonvexLoading…
StonvexStonvexStonvexCore line items from APO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $32.05B | $26.11B | $32.64B | $10.97B |
Operating Income | $6.68B | $7.43B | $5.59B | $-4.25B |
Net Income | $3.49B | $4.58B | $5.05B | $-1.96B |
EPS (Diluted) | $5.54 | $7.33 | $8.28 | $-3.43 |
Total Assets | $460.95B | $377.89B | $313.49B | $257.22B |
Total Liabilities | $418.43B | $346.92B | $288.24B | $241.82B |
Cash & Equivalents | $20.59B | $17.11B | $17.69B | $8.98B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 578.98M | 565.74M | 567.76M | 570.28M |